Coloplast reported 911M in Cash and Equivalent for its fiscal quarter ending in September of 2023.





Cash And Equivalent Change Date
Ambu A/S DKK 536M 169M Sep/2026
Brookdale Senior Living USD 323.37M 47.01M Sep/2026
Cencora USD 2.82B 638.79M Jun/2026
Coloplast 911M 497M Sep/2023
Encompass Health USD 76.2M 31.5M Sep/2026
Enovis USD 13.04M 475K Sep/2026
GE HealthCare Technologies USD 2.83B 747M Sep/2026
OPKO Health USD 300.76M 41.12M Jun/2026
Pediatrix Medical Group USD 311.92M 23.04M Sep/2026
Veradigm USD 492.6M 7.57M Sep/2022
Zimmer Biomet Holdings USD 399.9M 10.1M Sep/2026